Stay updated on Efficacy of Losmapimod in FSHD Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Losmapimod in FSHD Clinical Trial page.

Latest updates to the Efficacy of Losmapimod in FSHD Clinical Trial page
- Check4 days agoChange DetectedAdded the Locations section with multiple site entries in the US (California, Florida, Kansas, Maryland, Massachusetts, Missouri, New York, Ohio, Utah, Virginia, Washington) and Canada (Ontario, Quebec). Removed the HHS Vulnerability Disclosure section and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedPublication sourcing note now states PubMed auto-fills publications, and the revision tag shows v3.3.2 instead of v3.2.0.SummaryDifference0.1%

- Check33 days agoChange DetectedDeleted government funding status notice from the bottom of the page; core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedA new publication reference was added and study record dates updated. No changes to core endpoints or eligibility.SummaryDifference0.4%

- Check76 days agoChange Detected- Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check83 days agoChange DetectedVersion bump: upgrading from v3.0.2 to v3.1.0 with no additional substantive content changes detected.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Losmapimod in FSHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Losmapimod in FSHD Clinical Trial page.